Spray-On chemo tested for tough abdominal cancers
NCT ID NCT05285358
First seen Apr 10, 2026 · Last updated Apr 10, 2026
Summary
This early-stage study is testing the safety of a new method to deliver chemotherapy directly into the abdomen for patients with advanced bile duct or gallbladder cancer that has spread there. The method, called PIPAC, uses a special device to spray chemotherapy as a fine mist during a minimally invasive surgery, aiming to reach more cancer cells while potentially reducing side effects. Researchers will combine this new delivery method with standard chemotherapy drugs to see if the overall treatment is more tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.